Podiatrists in Spanish Fork, UT Accepting Medicare

6 Podiatrists found. Showing 1 - 6

Stoddard Foot & Ankle Pllc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 743 N Main St, Spanish Fork, UT 84660 Phone: 385-225-0961    Fax: 385-448-5058

Matthew Vernon Stoddard, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 743 N Main St, Spanish Fork, UT 84660 Phone: 385-225-0961    Fax: 385-448-5058

Nebo Foot & Ankle Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 65 W 200 N, Suite 1, Spanish Fork, UT 84660 Phone: 801-794-3856    Fax: 801-794-9882

Canyon Foot And Ankle Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 478 S Main St, Spanish Fork, UT 84660 Phone: 801-609-4743    Fax: 801-804-5545

Levi J Berry, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 478 S Main St, Spanish Fork, UT 84660 Phone: 801-609-4743

Michael L Nelson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 65 W 200 N, Suite1, Spanish Fork, UT 84660 Phone: 801-794-3856    Fax: 801-794-9882

News Archive

KemPharm commences KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm's proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.

AirStrip, Life Monitor form alliance to sell AirStrip solutions in New Zealand and Australia

AirStrip and Life Monitor Pty Ltd., a subsidiary of Cardioscan Pty Ltd., today announced the formation of a strategic partnership to sell AirStrip solutions in Australia and New Zealand. Both the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system will be available as part of the agreement.

Two viral gene targets needed in SARS-CoV-2 detection by PCR, say researchers

Researchers at the Chan Zuckerberg Biohub, San Francisco, and collaborators have warned against only targeting one viral gene when carrying out reverse transcriptase-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Lymphoseek receives FDA approval for breast cancer, melanoma

The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing surgery to remove tumor-draining lymph nodes.

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning medication clopidogrel versus the newer, more potent drug ticagrelor, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

Read more Medical News

› Verified 2 days ago